Chemomab Therapeutics Ltd. Comprehensive Income
Chemomab Therapeutics Ltd. (CMMB) reported Comprehensive Income of $27.12 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-03-17
- Chemomab Therapeutics Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was $27.12M, a 102.68% increase from fiscal 2018.
- Chemomab Therapeutics Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was $13.38M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|
| 2019-12-31 | $27.12M 10-K · filed 2020-03-17 |
| 2018-12-31 | $13.38M 10-K · filed 2020-03-17 |